日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Racial/ethnic differences in risk factors for non-cardia gastric cancer: an analysis of the Multiethnic Cohort (MEC) Study

非贲门胃癌风险因素的种族/民族差异：多民族队列（MEC）研究分析

期刊:Cancer Causes & Control
影响因子:2.1
doi:10.1007/s10552-024-01934-9
Adams, Alexandra; Gandhi, Atish; Friedmann, Patricia; Sarkar, Srawani; Rana, Brijesh; Epplein, Meira; Wilkens, Lynne; Huang, Brian Z; In, Haejin
胃癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Risks of hypertension and thromboembolism in patients receiving bevacizumab with chemotherapy for colorectal cancer: A systematic review and meta-analysis

接受贝伐单抗联合化疗治疗结直肠癌患者发生高血压和血栓栓塞的风险：系统评价和荟萃分析

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.6662
Chitkara, Akshit; Kaur, Nirmaljot; Desai, Aditya; Mehta, Devanshi; Anamika, Fnu; Sarkar, Srawani; Gowda, Nandini; Sethi, Prabhdeep; Thawani, Rajat; Chen, Emerson Y
肿瘤
肠癌
高血压
肿瘤免疫
心血管
发表日期：2023
文献求助 收藏

Respondent Driven Sampling Method of Recruitment for a Case Control Study of Gastric Cancer Risk

胃癌风险病例对照研究的受访者驱动抽样招募方法

期刊:Asian Pacific Journal of Cancer Prevention
影响因子:
doi:10.31557/APJCP.2023.24.11.3639
Cassel, Kevin; In, Haejin; Sarkar, Srawani; Rapkin, Bruce; Umadat, Goyal
胃癌
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Serum Pepsinogen as a Biomarker for Gastric Cancer in the United States: A Nested Case-Control Study Using the PLCO Cancer Screening Trial Data

美国血清胃蛋白酶原作为胃癌生物标志物的研究：一项基于PLCO癌症筛查试验数据的嵌套病例对照研究

期刊:Cancer Epidemiology Biomarkers & Prevention
影响因子:3.4
doi:10.1158/1055-9965.EPI-21-1328
In, Haejin; Sarkar, Srawani; Ward, Jessica; Friedmann, Patricia; Parides, Michael; Yang, Julie; Epplein, Meira
胃癌
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Socioeconomic Disparities in Gastric Cancer and Identification of a Single SES Variable for Predicting Risk

胃癌中的社会经济差异及预测风险的单一社会经济地位变量的确定

期刊:Journal of Gastrointestinal Cancer
影响因子:1.6
doi:10.1007/s12029-020-00564-z
Sarkar, Srawani; Dauer, Marc J; In, Haejin
胃癌
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏